Eloxx Pharmaceuticals, Inc. (ELOX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

Eloxx Pharmaceuticals, Inc. (ELOX) closed at USD 12.21 on 2026-10-14, a change of +10.9 % over the past year, with a market capitalization of USD 55.3M.

Eloxx Pharmaceuticals, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

Eloxx Pharmaceuticals, Inc. key figures

Previous close

USD 12.21 (2026-10-14)

1-year change

+10.9 %

Market cap

USD 55.3M

Enterprise value

USD 5.17M

P/E ratio (trailing)

3.71

P/E ratio (forward)

-19.30

EPS (trailing)

3.69

EPS (forward)

-0.71

PEG ratio

1.85

Price to book

1.19

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

1.90

Employees

10

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About Eloxx Pharmaceuticals, Inc.

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule product candidates that modulate the ribosome and promote readthrough of premature stop codons caused by nonsense mutations in the United States, Israel, and Australia. The company is developing exaluren, a eukaryotic ribosome-selective glycoside in a Phase 2 trial for the treatment of rare kidney diseases, including Alport syndrome with nonsense mutations, cystic fibrosis with nonsense mutations, and nephropathic cystinosis with nonsense mutations, as well as in a preclinical stage for the treatment of autosomal dominant polycystic kidney disease with nonsense mutations. It has collaboration with Almirall, S.A. to develop and commercialize ZKN-013, an oral ribosome modulating agent for the treatment of rare skin diseases, such as recessive dystrophic epidermolysis bullosa and junctional epidermolysis bullosa with nonsense mutations. Eloxx Pharmaceuticals, Inc. was incorporated in 1999 and is based in Arlington, Massachusetts.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for Eloxx Pharmaceuticals, Inc. and compare it with other stocks.